Support

2016–2021 Targeting STING for Treatment of CHB and Cancer
Gilead Sciences Research Center (GSRC-3)
 
2018-2022 Chemical biology for drugging undruggable targets (ChemBioDrug)
European Regional Development Fund (OP RDE), &Numero; CZ.02.1.01/0.0/0.0/16_019/0000729